This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Laboratorios Farmaceuticos Roui, S.a.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Nathalie Ubrich: Innovating Oral Absorption with Particulate Vectors
Introduction: Nathalie Ubrich is a prominent inventor based in Nancy, France, recognized for her contributions to pharmaceutical innovations. With her expertise in developing advanced delivery systems, she has a patent that enhances the oral absorption of active principles, making significant strides in the field of drug formulation.
Latest Patents: Ubrich holds a patent titled "Particulate vectors for improving oral absorption of active principles." This invention focuses on particulate vectors that consist of a polymeric matrix, incorporating at least a biodegradable polymer and a polycationic polymer. The aim of this innovation is to improve the efficiency of oral drug delivery systems, addressing a critical challenge in the pharmaceutical industry.
Career Highlights: Throughout her career, Nathalie Ubrich has made significant contributions to the field of pharmaceuticals. Her work at companies such as Laboratorios Farmaceuticos Roui S.A. and Laboratorios Farmaceuticos Rovi S.A. reflects her commitment to advancing medical science through innovative drug delivery methods.
Collaborations: Ubrich has collaborated with esteemed colleagues, including Philippe Maincent and Claude Vigneron. These partnerships have fostered a dynamic exchange of ideas and expertise, further enhancing the impact of her innovations on the pharmaceutical landscape.
Conclusion: Nathalie Ubrich's work exemplifies the spirit of innovation in the pharmaceutical industry. Her patent on particulate vectors is not just a testament to her skills as an inventor but also a significant advancement in improving oral drug absorption. As she continues to pursue her research, her contributions will undoubtedly play a vital role in shaping the future of drug delivery technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile